Philip Morris International (PMI) recorded an outstanding second-quarter and first-half performance, with strong contributions from Iqos and Zyn – despite supply constraints and the EU flavour ban.
The New-York-based company said its expansion of the Iqos portfolio remains active, with further market launches planned in the second half of the year. These include Delia – a consumable for the Iluma line with a more affordable price point, Levia herbal heated consumables, and the new Iluma i device range – which is currently only available in Japan.
